These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27271757)

  • 1. A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease.
    Whitin JC; Yu TT; Ling XB; Kanegaye JT; Burns JC; Cohen HJ
    PLoS One; 2016; 11(6):e0157024. PubMed ID: 27271757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased α1-antitrypsin levels in acute-phase Kawasaki disease as shown by SELDI-TOF MS analysis.
    Kanai T; Shiraishi H; Uehara R; Ito T; Momoi MY
    Pediatr Cardiol; 2012 Dec; 33(8):1343-7. PubMed ID: 22580770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
    Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC
    BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.
    Jone PN; Korst A; Karimpour-Fard A; Thomas T; Dominguez SR; Heizer H; Anderson MS; Glode MP; Sucharov CC; Miyamoto SD
    J Mol Cell Cardiol; 2020 Sep; 146():12-18. PubMed ID: 32634388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.
    Tremoulet AH; Dutkowski J; Sato Y; Kanegaye JT; Ling XB; Burns JC
    Pediatr Res; 2015 Nov; 78(5):547-53. PubMed ID: 26237629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
    Nakashima Y; Sakai Y; Mizuno Y; Furuno K; Hirono K; Takatsuki S; Suzuki H; Onouchi Y; Kobayashi T; Tanabe K; Hamase K; Miyamoto T; Aoyagi R; Arita M; Yamamura K; Tanaka T; Nishio H; Takada H; Ohga S; Hara T
    Cardiovasc Res; 2021 Jan; 117(1):96-108. PubMed ID: 31782770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
    Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
    Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
    Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
    Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
    Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
    J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma H2S predicts coronary artery lesions in children with Kawasaki disease.
    Sun Y; Yuan Y; Yan H; Wan H; Li X; Chen S; Li H; Tang C; Du J; Liu G; Jin H
    Pediatr Int; 2015 Oct; 57(5):840-4. PubMed ID: 25808254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms.
    Kusuda T; Nakashima Y; Murata K; Kanno S; Nishio H; Saito M; Tanaka T; Yamamura K; Sakai Y; Takada H; Miyamoto T; Mizuno Y; Ouchi K; Waki K; Hara T
    PLoS One; 2014; 9(11):e113054. PubMed ID: 25411968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
    Song HB; Zhang YD; Dong QW; Han LP; Qi RF; Bi BB; Ma L; Ma L; Zhang H
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
    Chen YL; Wang JL; Li WQ
    Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.
    He YE; Qiu HX; Wu RZ; Rong X; Xu HT; Xiang RL; Chu MP
    J Cardiovasc Transl Res; 2020 Apr; 13(2):204-214. PubMed ID: 31428922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.